Citations 327
A Phase 1b Dose Escalation and Expansion Study of SNDX-5613, Azacitidine (AZA) and Venetoclax (VEN) in Newly Diagnosed, Patients ≥ 60 Years with Untreated NPM1-Mutated/ FLT3-Wild Type AML or KMT2A-Rearranged Acute Myeloid Leukemia (AML
Johnson, Mary Ann , Huang, Ying , Swords, Ronan , Stein, Eytan M. , Foran, James M. , Baer, Maria R. , Kovacsovics, Tibor , Olin, Rebecca L. , Blum, William , Schiller, Gary J. , Redner, Robert L. , Al‐Mansour, Zeina , Curran, Emily , Heerema, Nyla A. , Martycz, Molly , Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O. , Stefanos, Mona , Druggan, Franchesca , Burd, Amy , Borate, Uma , Byrd, John C. , Byrd, John C , Zeidner, Joshua F. , Foster, Matthew C , Johnson, Mary, Stock, Wendy , Madanat, Yazan F. , Lin, Tara L. , Chen, Timothy Frank , Levine, Ross L. , Druker, Brian J , Mims, Alice S
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9070-9073
Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival
Fleti, Farah, Singh, Amritpal , Al‐Kali, Aref , Foran, James M. , Elliott, Michelle A. , Begna, Kebede H. , Khera, Nandita , Abdelmagid, Maymona, Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B. , Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6940-6941
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Gangat, Naseema , Ilyas, Rimal, Begna, Kebede H. , Al‐Kali, Aref , Patnaik, Mrinal M. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Elliott, Michelle A. , Foran, James M. , Palmer, Jeanne , Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , McCullough, Kristen , Hogan, William J. , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9675-9676
Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Greipp, Patricia T. , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Badar, Talha , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12353-12354
The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification
Foran, James M. , Tandra, Anand, Mattour, Ahmad, Perkins, Andrew C. , Rodríguez‐Macías, Gabriela , Sibai, Hassan , Sun, Yan , Potluri, Jalaja , Harb, Jason G., How, Jonathan, Perkins, Andrew C , Passamonti, Francesco , Stefano, Valerio De , Fox, María Laura , McMullin, Mary Frances , Qin, Qin
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 583-585
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020
A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed IDH2-Mutant AML Patients: 3-Year Follow-up
Stein, Eytan M. , Huang, Ying , Dunbar, Andrew , Baer, Maria R. , Kovacsovics, Tibor , Blum, William , Schiller, Gary J. , Olin, Rebecca L. , Foran, James M. , Litzow, Mark R. , Patel, Prapti A. , Boyiadzis, Michael , Collins, Robert H. , Chervin, Jordan , Vergilio, Jo‐Anne, Heerema, Nyla A. , Rosenberg, Leonard, Yocum, Ashley O. , Druggan, Franchesca , Marcus, Sonja, Stefanos, Mona , Martycz, Molly , Borate, Uma , Burd, Amy , Byrd, John C. , Byrd, John C , Cai, Sheng F , Stock, Wendy , Lin, Tara L. , Foster, Matthew C , Shoben, Abigail B. , Chen, Timothy Frank , Druker, Brian J , Mims, Alice S , Levine, Ross L.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2016-2019
Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia
Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12238-12240
The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal Cytopenias
Smith, Alexandra N., Ali, Najla Al , Coombs, Catherine C. , Foran, James M. , Tsai, Charlton , Amanam, Idoroenyi , Lai, Catherine , Deeg, Joachim, Dinner, Shira, Chandhok, Namrata S. , Soong, Deborah, Brunner, Andrew M. , Geyer, Susan M. , Padron, Eric , Patnaik, Mrinal M. , Al‐Kali, Aref , Xie, Zhuoer , Komrokji, Rami S. , Patel, Anand , Saygin, Caner , Zeidan, Amer M. , Bewersdorf, Jan Philipp , Kishtagari, Ashwin , Zeidner, Joshua F. , Madanat, Yazan F. , Badar, Talha , Desai, Pinkal , Griffiths, Elizabeth A. , Malki, Monzr M. Al , Lai, Catherine, Adès, Lionel , Yi, Cecilia Arana , Osman, Afaf E.G. , Abaza, Yasmin , Taylor, Justin , Carraway, Hetty E. , Singh, Abhay , Savona, Michael R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2887-2890
U2AF1 Mutant Clonal Hematopoiesis Is Infrequent, Context Dependent, and Commonly Co-Occurs with BCOR Mutations
Pritzl, Stephanie , Lasho, Terra, Finke, Christy M. , Mangaonkar, Abhishek A. , Gangat, Naseema , Al‐Kali, Aref , Viswanatha, David S., He, Rong, Foran, James M. , Patnaik, Mrinal M. , Badar, Talha , Ferrer, Alejandro , McCullough, Kristen , Fernandez, Jenna , He, Rong
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11408-11409